Related Experiment Video
Updated: Aug 14, 2025

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis
Rakesh Bhatia1, Jawed Akhtar Siddiqui1,2, Koelina Ganguly1
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Abstract:
Mucin4 (MUC4) appears early during pancreatic intraepithelial neoplasia-1 (PanIN1), coinciding with the expression of epidermal growth factor receptor-1 (EGFR). The EGFR signaling is required for the onset of Kras-driven pancreatic ductal adenocarcinoma (PDAC); however, the players and mechanisms involved in sustained EGFR signaling in early PanIN lesions remain elusive. We generated a unique Esai-CRISPR-based Muc4 conditional knockout murine model to evaluate its effect on PDAC pathology. The Muc4 depletion in the autochthonous murine model carrying K-ras and p53 mutations (K-rasG12D; TP53R172H; Pdx-1cre, KPC) to generate the KPCM4-/- murine model showed a significant delay in the PanIN lesion formation with a significant reduction (p < 0.01) in EGFR (Y1068) and ERK1/2 (T202/Y204) phosphorylation. Further, a significant decrease (p < 0.01) in Sox9 expression in PanIN lesions of KPCM4-/- mice suggested the impairment of acinar-to-ductal metaplasia in Muc4-depleted cells. The biochemical analyses demonstrated that MUC4, through its juxtamembrane EGF-like domains, interacts with the EGFR ectodomain, and its cytoplasmic tail prevents EGFR ubiquitination and subsequent proteasomal degradation upon ligand stimulation, leading to sustained downstream oncogenic signaling. Targeting the MUC4 and EGFR interacting interface provides a promising strategy to improve the efficacy of EGFR-targeted therapies in PDAC and other MUC4-expressing malignancies.
Insights
Mucin4 (MUC4) protein promotes pancreatic cancer by stabilizing epidermal growth factor receptor (EGFR) signaling. Depleting MUC4 delays tumor formation and reduces EGFR activity, offering a new therapeutic target for pancreatic ductal adenocarcinoma (PDAC).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Mucin4 (MUC4) expression is an early event in pancreatic intraepithelial neoplasia (PanIN), coinciding with epidermal growth factor receptor (EGFR) signaling, which is crucial for Kras-driven pancreatic ductal adenocarcinoma (PDAC).
- The precise mechanisms sustaining EGFR signaling in early PanIN lesions remain unclear.
Purpose of the Study:
- To investigate the role of MUC4 in PDAC development and EGFR signaling using a conditional knockout murine model.
- To elucidate the molecular interaction between MUC4 and EGFR in PDAC pathogenesis.
Main Methods:
- Generation of a Muc4 conditional knockout murine model (KPCM4-/-) with K-ras and p53 mutations.
- Analysis of PanIN lesion formation, EGFR and ERK1/2 phosphorylation, and Sox9 expression in KPCM4-/- mice.
- Biochemical assays to determine the interaction interface between MUC4 and EGFR.
Main Results:
- Muc4 depletion significantly delayed PanIN lesion formation in KPCM4-/- mice.
- Reduced phosphorylation of EGFR (Y1068) and ERK1/2 (T202/Y204) was observed in PanIN lesions of KPCM4-/- mice.
- Decreased Sox9 expression indicated impaired acinar-to-ductal metaplasia in MUC4-depleted cells, and MUC4 was shown to prevent EGFR ubiquitination and degradation.
Conclusions:
- MUC4 interacts with EGFR, stabilizing its signaling pathway by preventing degradation.
- Targeting the MUC4-EGFR interaction interface presents a potential therapeutic strategy for PDAC and other MUC4-expressing cancers.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
PI3K/mTOR/AKT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal